Effects of Fullerene Derivatives on Activity of Ca2+-ATPase of the Sarcoplasmic Reticulum and cGMP Phosphodiesterase

被引:1
作者
Tat'yanenko, L. V. [1 ]
Khakina, E. A. [1 ]
Zhilenkov, A. V. [1 ]
Troshin, P. A. [1 ]
Dobrokhotova, O. V. [1 ]
Pikhteleva, I. Yu. [1 ]
Kotel'nikov, A. I. [1 ]
机构
[1] Russian Acad Sci, Inst Problems Chem Phys, Chernogolovka, Moscow Region, Russia
关键词
Ca2+-Mg2+-ATPase of the sarcoplasmic reticulum; cGMP phosphodiesterase; inhibition; fullerene derivatives; CHLOROFULLERENE C60CL6; COMPLEXES;
D O I
10.1007/s10517-017-3794-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of new water-soluble polysubstituted fullerene C60 (PFD) derivatives on activity of Ca2+-Mg2+ ATPase of the sarcoplasmic reticulum and cGMP phosphodiesterase. All examined fullerene derivatives inhibited activity of both enzymes. For instance, PFD-I, PFD-II, PFD-III, PFD-V, PFD-IX, PFD-X, and PFD-XI in a concentration of 5x10(-5) M completely inhibited hydrolytic and transport functions of Ca2+-ATPase. These compounds in a concentration of 5x10(-6) suppressed active transport of calcium ions by 51 +/- 5, 77 +/- 8, 52 +/- 5, 52 +/- 5, 100 +/- 10, 80 +/- 8, and 100 +/- 10%, respectively, and inhibited ATP hydrolysis by 31 +/- 3, 78 +/- 8, 18 +/- 2, 29 +/- 3, 78 +/- 8, 63 +/- 7, and 73 +/- 9%, respectively, uncoupling the hydrolytic and transport functions of the enzyme. PFD-I noncompetitive and reversibly reduced activity of Ca2+-ATPase (K-i=2.3x10(-6) M). All the studied fullerene derivatives (except for PFD-VII) inhibited cGMP phosphodiesterase by more than 80% in concentration of 10(-4) M and higher and by more than 50% in concentration of 10(-5) M. PFD-I is a non-competitive reversible inhibitor of cGMP phosphodiesterase (K-i=7x10(-6) M). These results allow us to expect antimetastatic, antiaggregatory, antihypertensive and vasodilative activity of the studied compounds.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 15 条
[1]  
BEREZIN IV, 1973, PRACTICAL COURSE CHE, P77
[2]   Cyclic GMP phosphodiesterase-5: Target of sildenafil [J].
Corbin, JD ;
Francis, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :13729-13732
[3]  
FIDLER IJ, 1990, CANCER RES, V50, P6130
[4]  
Granik VG, 2004, NEW WAY DRUG DEV
[5]  
HONN KV, 1983, P SOC EXP BIOL MED, V174, P16
[6]   Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development [J].
Jeon, YH ;
Heo, YS ;
Kim, CM ;
Hyun, YL ;
Lee, TG ;
Ro, S ;
Cho, JM .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (11) :1198-1220
[7]   Highly selective reactions of C60Cl6 with thiols for the synthesis of functionalized [60]fullerene derivatives [J].
Khakina, Ekaterina A. ;
Yurkova, Anastasiya A. ;
Peregudov, Alexander S. ;
Troyanov, Sergey I. ;
Trush, Vyacheslav V. ;
Vovk, Andrey I. ;
Mumyatov, Alexander V. ;
Martynenko, Vyacheslav M. ;
Balzarini, Jan ;
Troshin, Pavel A. .
CHEMICAL COMMUNICATIONS, 2012, 48 (57) :7158-7160
[8]   Facile preparation of amine and amino acid adducts of [60]fullerene using chlorofullerene C60Cl6 as a precursor [J].
Kornev, Alexey B. ;
Khakina, Ekaterina A. ;
Troyanov, Sergey I. ;
Kushch, Alla A. ;
Peregudov, Alexander ;
Vasilchenko, Alexey ;
Deryabin, Dmitry G. ;
Martynenko, Vyacheslav M. ;
Troshin, Pavel A. .
CHEMICAL COMMUNICATIONS, 2012, 48 (44) :5461-5463
[9]  
RITOV VB, 1977, DOKL AKAD NAUK SSSR+, V233, P730
[10]   The plasma membrane Ca2+-ATPase in spontaneously hypertensive rats [J].
Roufogalis, BD ;
Chen, S ;
Kable, EPW ;
Kuo, TH ;
Monteith, GR .
NA/K-ATPASE AND RELATED TRANSPORT ATPASES: STRUCTURE, MECHANISM, AND REGULATION, 1997, 834 :673-675